Methods for the treatment of ocular angiogenesis, retinal edema, retinal ischemia and Diabetic Retinopathy by using Selective inhibitors of tyrosine kinase receptors.

摘要

The present Invention provides compositions and Methods for treating ocular neovascularisation angiogenesis, retinal edema, Diabetic Retinopathy and / or esquemia retinal to prevent loss of Visual Acuity associated with these conditions.More specially, The Invention provides compositions containing inhibitors of the tyrosine kinase receptor binding profiles that are unique and their use in the treatment of Eye disorders.